Jefferies Group LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	SELL	$71.48 - $86.85 $1.54 Million - $1.87 Million	-21,500 Reduced 68.25%	10,000 $828,000
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $1.54 Million - $1.87 Million	-21,500 Reduced 68.25%	10,000 $829,000
Q3 2021 Sep 21, 2023	BUY	$74.77 - $85.47 $1.23 Million - $1.41 Million	16,500 Added 110.0%	31,500 $2.43 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $1.23 Million - $1.41 Million	16,500 Added 110.0%	31,500 $2.44 Million
Q2 2021 Aug 20, 2021	SELL	$75.51 - $84.79 $112 Million - $126 Million	-1,485,000 Reduced 99.0%	15,000 $1.25 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $112 Million - $126 Million	1,485,000 Added 9900.0%	1,500,000 $1.25 Million
Q1 2021 Sep 21, 2023	SELL	$74.73 - $90.69 $732,354 - $888,762	-9,800 Reduced 39.52%	15,000 $1.13 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $732,354 - $888,762	-9,800 Reduced 39.52%	15,000 $1.13 Million
Q4 2020 Sep 21, 2023	BUY	$72.61 - $90.2 $1.8 Million - $2.24 Million	24,800 New	24,800 $2.17 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $1.09 Million - $1.35 Million	15,000 Added 153.06%	24,800 $2.18 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $323,415 - $589,635	4,500 Added 84.91%	9,800 $746,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $5.03 Million - $6.83 Million	-70,500 Reduced 93.01%	5,300 $448,000
Q3 2019 Nov 13, 2019	BUY	$67.4 - $85.11 $4.28 Million - $5.4 Million	63,500 Added 516.26%	75,800 $5.11 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $731,185 - $854,490	9,100 Added 284.38%	12,300 $1.05 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $1.18 Million - $1.38 Million	-14,000 Reduced 81.4%	3,200 $284,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $2.63 Million - $3.48 Million	-32,800 Reduced 65.6%	17,200 $1.47 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $4.04 Million - $4.76 Million	50,000	50,000 $4.46 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.29 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$931 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$703 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account